Professional Documents
Culture Documents
The Philippine In the Philippines National And Nutrition Health Survey (NNHeS) 2008 data set, the
DiabCare
NHAES 2008 (WHO A. 7.2 prevalence of DIABETES was found to be 7.2 %, a prevalence estimate that
2008 Vol 50
Criteria) statistics for B. 9.1 closely approximates the projections of the IDF for that year.
1 No. 1 Jan-
prevalence of C. 14.2 On the other hand, the prevalence of PRE-DIABETES in the 2008 Philippine
Mar. 2012 pp.
prediabetes in the D. 12 NNHeS was found to be 9.1% (ANSWER) and 14 % using the WHO and ADA
15
country is __% criteria respectively.
Maturity onset diabetes of the young (MODY) and monogenic diabetes are
subtypes of DM characterized by autosomal dominant inheritance, early onset
of hyperglycemia (usually <25 years; sometimes in neonatal period), and
Maturity onset A. Autosomal recessive
impaired insulin secretion.
diabetes of the B. Onset 26-30 years old
Harrison’s
young (MODY) is a C. Insulin receptor can
3 Mutations in the insulin receptor cause a group of rare disorders characterized by 19th ed ch
sub-type of DM and cause DM type 2
severe insulin resistance. Several monogenic forms of DM have been identified. 417 p2400
one of these D. Affects Liver and
statements are true. Kidneys More than 10 different variants of MODY, caused by mutations in genes encoding
islet-enriched transcription factors or glucokinase. As their names imply these
transcription factors are expressed in the liver but also in other tissues
including the pancreatic islets and kidney.
Management
of
A. Home based glucose
Hyperglycemi
of 70-30mg/dl
a in
B. An HbA1C of <7% with
Hospitalized
previous episodes of
Which of the Glycemic targets in the non-critical care setting 3.1 We recommend a premeal Patients in
hypoglycemia
following is true glucose target of less than 140 mg/dl (7.8 mmol/liter) and a random BG of less Non-Critical
C. Admitted critically ill-
4 regarding glycemic than 180 mg/dl (10.0 mmol/liter) for the majority of hospitalized patients with non- Care Setting:
premeal glucose of
targets in a diabetic critical illness. An Endocrine
<140mg/dl
patient? Society
D. Admitted non
Clinical
critically ill patient-
Practice
random blood
Guideline
glucose <180mg/dl
P2
Harrison’s
19th ed
Based on the results of the patient, he has positive FBS score so he is diagnosed
as DM however as stated in the notes repeat testing should be done on a
separate day within 2 weeks to confirm the diagnosis, except in the presence
of hyperglycemic crises, in which case the patient should be treated as having
diabetes.
Unite for
A 45 yo M with an A. Repeat the FBS after 1
Diabetes
FBS of 127 mg/dL year
CPG for the
claims to have been B. Repeat FBS within 2
Diagnosis
stressed during the weeks
and
week. He denies any C. Obtain plasma glucose
6 Management
weight loss, after a 75 g oral
of Diabetes
polydipsia and glucose challenge
polyuria. What is D. Start the patient on
Under
next step in non-pharmacologic
Screening for
management? treatment
DM
Which of the
following tests is the A. Fasting blood glucose
Harrison’s
estimate of plasma B. 2 hours postprandial The glycemic index is an estimate of the postprandial rise in the blood glucose
11 19th Edition,
glucose after C. OGTT when a certain amount of that food is consumed.
p. 2409
ingesting a certain D. Glycemic index
amount of food?
A. Carbohydrate sources
high in protein should
be used to prevent
hypoglycemia
B. Fat quality appears
Which of the to be more important
following is than quantity Harrison’s
recommended C. Strong evidence 19th Edition,
12
medical nutrition supports the use of Chapter 418,
therapy for Diabetes cinnamon to treat page 2409
Mellitus? diabetes
D. Omega -3
supplementation helps
in the reduction of
cardiovascular risk
in high risk patients
Batch Atlas
Whisper page
A. To increase insulin 3
uptake before exercise
A. INCORRECT If an individual is taking insulin and/or insulin secretagogues,
B. To ingest added http://www.nd
physical activity can cause hypoglycemia if medication dose or carb
carbohydrates if pre- ei.org/ADA-
consumption is not altered
In prescribing exercise blood glucose diabetes-
B. INCORRECT Added carbohydrate should be ingested when pre-exercise
individualized is <250mg/dL management-
13 glucose is <100 mg/dL (5.6 mmol/L)
physical activity, C. To avoid vigorous guidelines-
C. CORRECT Delay exercise if blood glucose is > 14 mmol/L (250mg/dL) and
ADA recommends: exercise if ketones lifestyle-
ketones are present;
are present changes-
D. INCORRECT Resistance training ≥2 times/wk (in absence of
D. Resistance exercise medical-
contraindications)
for patients with retinal nutrition-
neuropathy therapy-
physical-
activity.aspx.
“Cardiovascular risk is lower and not equivalent in a younger individual with a brief
A. >35 years old Harrisons
Formal exercise duration of type 2 DM compared to an older individual with long standing type 2
B. > 5 yrs T2DM CH419 p2427
tolerance testing is DM...Because of the extremely high prevalence of underlying CVD in individuals
C. Microvascular Cardiovascul
14 not warranted in with diabetes (especially in type 2 DM), evidence of atherosclerotic vascular
complications in ar Morbidity
which of the disease (e.g. cardiac stress test) should be sought in an individual with diabetes
T2DM and Mortality
following individuals: who has symptoms suggestive of cardiac ischemia or peripheral or carotid arterial
D. Orthostatic dizziness paragraph 2
disease.”
A. Insulin
Most commonly
B. Glimepiride Metformin, if not contraindicated and if tolerated, is the preferred initial
15 used initial agent for UNITE
C. Metformin pharmacological agent for type 2 diabetes
type 2 DM
D. Acarbose
A. Glargine is an example
of short acting insulin
B. Usually the duration of
short acting insulin is
10-16 hrs
Which of the
C. Regular insulin has
following statements Harrison Ch
17 an onset of 30 min to
is true of short acting 418
1 hour and duration
insulin?
of 4-6 hrs
D. Some short acting
insulin has onset of
<25 min and peaks at
3-4 hrs
A. The onset of action is
1-2h
B. It acts best as a single
agent
A. Onset is 2 to 4
C. It is best used in
Which of the ff is B. Usually paired with a short acting Harrison table
18 treating postprandial
true of basal insulin? C. Not for post prandial. Short acting is more appropriate 418.4
rise of blood sugar
D. Best answer. NPH is an example and peak is 4-10.
level
D. NPH is an example
and it peaks at 6-10 h
THE ADA
A. Insulin
recommends this
B. biguanides Although not as effective as lifestyle interventions, drug therapy with metformin and
20 medication for those ADA
C. GLPT-1 acarbose (Precose) has been shown to prevent the progression of IGT to diabetes
who have impaired
D. Sulfonylureas
glucose intolerance
A. Less Expensive
B. Less adverse effect When glycemic targets are not achieved with one drug given at Unite for
What is the value of C. Patient is more the maximum effective dose (optimal dose or half maximum), diabetes
22
multiple treatment? compliant to tx another drug from another pharmacologic class should be added CPG, page
D. More pathological rather than increasing the first drug to its maximum dose 31
target
Which of the
A. Sulfonylureas A. Sulfonylureas - increase insulin secretion
following acts
B. DPP4 inhibitors B. DPP4 inhibitors - prolong endogenous GLP-1 action Harrisons, pg.
primarily by
23 C. Thiazolidinediones C. Thiazolidinediones - decrease insulin resistance, increase glucose 2214
increasing the
D. Alpha Glucosidase utilization Table 418-5
body’s sensitivity to
inhibitors D. Alpha glucosidase inhibitors
insulin?
A. Aspart
Which of the
B. Regular Unite for
26 following insulin
C. Glulisine diabetes CPG
provides basal level?
D. Glargine
DM patient
A. Measuring the ankle
complains of
brachial index
numbness of lower
B. Checking for dorsalis
extremities and Unite for
27 pedis pulse B or C, but since neurologic ang complaint and not CV related so, C?
difficulty walking. diabetes CPG
C. Testing for vibratory
Which of the
sense
following is
D. Order electromyogram
appropriate?
A. Mononeuropathy
Most common type
B. Autonomic neuropathy The most common form of diabetic neuropathy is DISTAL SYMMETRIC Harrisons
of neuropathy in
28 C. Proximal neuropathy POLYNEUROPATHY. Most freq presents with distal sensory loss and pin, up to ch419 p.
DM?
D. Symmetrical distal 50% of patients do not have symptoms of neuropathy 2426
neuropathy
A. High LDL
harrisons
Most common B. Low HDL The most common pattern of dyslipidemia is hypertriglyceridemia and reduced
29 chapt 419
dyslipidemia in DM? C. High triglycerides high-density lipoprotein (HDL) cholesterol levels.
pp.2428
D. High cholesterol
A. Serum creatinine The first step in the screening and diagnosis of diabetic nephropathy is to measure Medscape:
B. Creatinine clearance albumin in a spot urine sample, collected either as the first urine in the morning or Diabetic
What is the most (eGFR) at random, for example, at the medical visit. This method is accurate, easy to Nephropathy:
30 sensitive test for dm C. Dipstick test for perform, and recommended by American Diabetes Association guidelines.The Diagnosis,
nephropathy? proteinuria results of albumin measurements in spot collections may be expressed as urinary Prevention,
D. Microalbumin/crea albumin concentration (mg/l) or as urinary albumin-to-creatinine ratio (mg/g or and
ratio mg/mmol). Treatment
A. Hemorrhage is the “Establishing that strict glycemic control reduces the risk of macrovascular
hallmark of diabetic complications of diabetes has proved much more elusive than the beneficial effects
retinopathy on microvascular complications such as retinopathy and renal disease.”
Which of the B. Insulin resistance is
Harrison’s
31 following statements the pathologic process A. WRONG. The appearance of neovascularization in response to retinal
19th Ed
is true? of DM 1 hypoxemia (not hemorrhage) is the hallmark of proliferative diabetic
C. 25% of complications retinopathy
develop in type 2 DM B. WRONG. Should be type 2 DM
patients C. WRONG. Should be 50%. 50% (not 25% of T2DM are diagnosed with
D. There is no proof or complications
evidence that
controlling glycemic
index can prevent
macrovascular
complications
A. Hypoglycemia
A male patient with a 6 year history was brought to the B. Accelerated atherosclerosis
ER because of unresponsiveness. He was seen a C. Hyperosmolar state
month ago because of slight pedal edema. An D. Insufficient blood glucose control
antidiabetic was prescribed along with diuretics and
lab tests were requested. He took the meds for a Hypoglycemia
week, did not do the tests and was lost to follow-up. From the case:
Three days ago, he had a finger prick for glucose -brought to the ER because of unresponsiveness
Harrisons
during a free clinic and was told the result was high. - took antidiabetic medications
33 Page 2420,
He took the meds leftover from the previous - decreased his food intake and skipped evening meals
2431
prescription regularly for 3 days. He also decreased - unresponsive the next morning
his food intake and skipped evening meals to control *Neuroglycopenic manifestations of hypoglycemia are the direct result of CNS
his blood sugar. He was unresponsive the next glucose deprivation (behavioral changes, confusion, fatigue, seizure, loss of
morning. consciousness and if severe, death)
*Hypoglycemia is most commonly caused by drugs used to treat DM or by
This problem is likely the result of which of the exposure to other drugs, including alcohol
following? *Conventional risk factor for hypoglycemia in diabetes:
→ influx of exogenous glucose is reduced (e.g., during an overnight fast or
after missed meals or snacks)
Hyperosmolar state
*Prototypical patient with HHS is an elderly with type 2 DM, with a several week
history of polyuria, weight loss and diminished oral intake that culminates in mental
confusion, lethargy or coma.
*PE reflects profound dehydration and hyperosmolality and reveals hypotension,
tachycardia, and altered mental status.
*Often precipitated by serious, concurrent illnes such as MI or stroke, sepsis and
pneumonia
In SMBG, a small drop of blood and an easily detectable enzymatic reaction allow
A. Serum sodium
measurement of the capillary plasma glucose. Many glucose monitors can rapidly
What initial test will B. Plasma glucose
and accurately measure glucose (calibrated to provide plasma glucose value even
34 be most useful in the C. Spinal CT scan compi
though blood glucose is measured) in small amounts of blood (3–10 μL) obtained
above case? D. Capillary blood
from the fingertip; alternative testing sites (e.g., forearm) are less reliable,
glucose
especially when the blood glucose is changing rapidly (postprandially).
A. GDM
B. DM T1
A 38 year old pregnant woman, now on her 2nd C. DM T2
trimester was referred to you by her OB for D. Other Types of DM
management of her elevated blood glucose. She is a
known diabetic for 3 years, on metformin 500 mg TID Harrisons,
35 • Diabetes diagnosed at the initial prenatal visit should be classified as overt
prior to pregnancy with good glycemic control. Upon page 2400
diabetes rather than GDM.
learning that she is pregnant, she stopped her
• Overt diabetes can either be DM type 1, type 2 or other types. Since the
metformin but did not bother to visit any of her doctors
patient is taking Metformin, an oral hypoglycemic agent, probably she has
for glucose management. The patient has:
DM type 2.
• Glucose intolerance developing DURING pregnancy is classified as GDM.
A. Insulin
38 yo woman, 2nd tri, elevated bg. Diabetic 3yrs B. Metformin
metformin 500mg tid. Upon learning she was C. Acarbose
module 33 IM
36 pregnant, stopped metformin and did not visit any of D. Gliclazide
DM whis
her doctors. What is the ideal medication for her at this
time? The efficacy and safety of insulin have made it the standard for treatment of
diabetes during pregnancy
https://www.
medicinenet.c
om/hyperkale
One example of potassium shift causing hyperkalemia is diabetic ketoacidosis. mia/article.ht
Insulin is vital to patients with type 1 diabetes. Without insulin, patients with type 1 m
A. Increased renal diabetes can develop severely elevated blood glucose levels. Lack of insulin also
reabsorption causes the breakdown of fat cells, with the release of ketones into the blood,
Which of the ff
B. Decreased GI loss turning the blood acidic (hence the term ketoacidosis). The acidosis and high Also
38 increases serum
C. Extracellular shift of glucose levels in the blood work together to cause fluid and potassium to mentioned by
potassium level?
K+ move out of the cells into the blood circulation. Patients with diabetes often Doc Sevidal
D. Intracellular …. also have diminished kidney capacity to excrete potassium into urine. The and Doc
combination of potassium shift out of cells and diminished urine potassium Basang in
excretion causes hyperkalemia. their
respective
lectures in the
past
Algorithm
Management of this
For hyperglycemia and ketonemia/ketonuria. Hyperglycemi
patient include. A. Fluids 1-3L 0.45% NS
c crises in
Refer to case #37 for 2-3 h
A. Complete initial evaluation and start IV fluids 1.0 L of 0.9% NaCl per hour adult patients
B. Insulin drip and
B. Insulin:regular IV route 0.1 U/kg/bwt as bolus with diabetes
39 bolus 1.0 u/kg
C. If low bicarb check ph if <6.9 administer 100 mmol in 400 ml H20 +20 meq Kcl care vol 32
Kani ba, DKA ni C. Bicarbonate for low
infuse for 2 hrs number 7 july
siya. Kailangan ug bicarb
D. When serum glucose reaches 200 mg/dl (DKA) or 350 (HHS) change to 5% 2009
katong lab values D. D5NSS if 250-300
dextrose with .45%nacl at 150-250 ml/h
from the previous glucose
Harrison’s
numbers.
Significance of Ketone Measurements
● b-hydroxybutyrate can only be measured using specialized equipment not
Source:
What is the most available in most in-house laboratories
A. Serum osmolality
reliable index in ● During recovery, results from the nitroprusside test might wrongly indicate
B. Urine ketones Doc Sevidal
40 measuring the that the ketone concentration is not improving or is even getting worse
C. Urine glucose and Doc
response to ● The best biochemical indicator of resolution of keto-acid excess is
D. Serum anion gap Basang’s
treatment? simply the anion gap
Lectures
● There is no rationale for follow-up ketone measurements after the initial
measurement has returned high
Less stringent Hba1c goals (such as 8%) may be appopriate for patients with
Which of the
1. Extensive comorbidities severe hypoglycemia, limited life expectancy, advanced microvascular or
following allows
2. Long life expectancy macrovascular complications, extensive comorbid conditions or long
46 less stringent WBL
3. Long Standing DM standing DM, to whom the general goal is difficult to attain despite diabetes self
Hba1c
4. No CVD risk management education, appopriate glucose monitoring, and effective doses of
monitoring?
multiple glucose lowering agents including insulin.
1. Volume depletion
2. Excess of
counterregulatory
Kussmaul breathing is a deep and labored breathing pattern often associated with
hormones increase
These features severe metabolic acidosis, particularly diabetic ketoacidosis (DKA).
lipolysis
48 distinguish DKA
3. Precipitated by
from HHS: DKA results from relative or absolute insulin deficiency combined with
infectionand insulin
counterregulatory hormone excess, both are necessary for DKA to develop
deficiency
4. Nausea, vomiting,
Kussmaul respiration